Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107431 · ClinicalTrials.gov registry record · NA
Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin
A NA study of Pre Diabetes, sponsored by Integrative Health Technologies.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT01107431 is a NA study of Pre Diabetes that has completed, run by Integrative Health Technologies. The registered enrollment target is 70 participants, below the 728-participant average among 59 other Pre Diabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01107431, a NA study of Pre Diabetes, has completed, sponsored by Integrative Health Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT L-Arabinose and Chromium
- DIETARY_SUPPLEMENT Sucrose without dietary Supplement
Study Locations (1)
Texas
- Integrative Health Technologies - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01107431
The ClinicalTrials.gov registry entry for NCT01107431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 59 other Pre Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Integrative Health Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 2 interventions - of which L-Arabinose and Chromium is the first listed.
NCT01107431 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01107431 about?
NCT01107431 is a clinical study titled "Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin". This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).
What is the current status of trial NCT01107431?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2008-12. Estimated completion is 2009-12.
What conditions does trial NCT01107431 study?
This clinical trial studies the following conditions: Pre Diabetes.
What interventions are being tested in trial NCT01107431?
The interventions under investigation include: L-Arabinose and Chromium (DIETARY_SUPPLEMENT), Sucrose without dietary Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01107431?
This trial is sponsored by Integrative Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107431 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals
RECRUITING · NA
-
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
RECRUITING · NA
-
Stand Up for Your Health with a Sit-stand Desk
RECRUITING · NA
-
Sisters of Heart (Hermanas de Corazón): A Community Health Worker Initiative for Improving Heart Health in Migrant Farmworker Women
RECRUITING · NA
-
Full Plate Living Nutrition Education Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.